by mg6754@ | Apr 5, 2022 | Genetic Testing
We have the technology to start a new era in medicine by precisely matching drugs to people’s genetic code, a major report says.Some drugs are completely ineffective or become deadly because of subtle differences in how our bodies function.The British Pharmacological...
by mg6754@ | Apr 5, 2022 | Genetic Testing
Pharmacogenomic testing could save the NHS money in the long term and reduce the risks of side-effects. Genetic testing to predict how individuals will respond to common medicines should be implemented without delay to reduce the risk of side-effects and ensure that...
by mg6754@ | Nov 22, 2021 | Pharmacogenomics
Getting Pharmacogenomicsinto the Clinic This Medical News Article Discusses Barriers to Widespread Implementation of Genotype-Guided Prescribing What if there were a way to know if a depressed patient would respond to an antidepressant—before it was prescribed? Or to...
by mg6754@ | Nov 21, 2021 | Health and Wellbeing
Polygenic Risk Score Predicts Statin Response Harlan M. Krumholz, MD, SM ReviewingNatarajan P et al. Another stride towards personalised medicine through Statins response. The aspiration of precision medicine is to personalize our approach to individual patients. One...
by mg6754@ | Nov 15, 2021 | Hereditary Breast & Ovarian Cancer, Uncategorised
Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry The American Journal of Obstetrics & Gynecology Population-based BRCA1 / BRCA2 testing has been investigated extensively in the Ashkenazi-Jewish (AJ) population and has been...
Recent Comments